Feladilimab
Feladilimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target inducible T-cell costimulator.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
8 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Head and neck neoplasms | D006258 | — | 2 | 2 | — | — | 2 |
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | FELADILIMAB |
| INN | feladilimab |
| Description | Feladilimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target inducible T-cell costimulator. |
| Classification | Antibody |
| Drug class | vasodilators (undefined group); monoclonal antibodies |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL4297969 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | OUP4QB2A3R (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
ICOS
ICOS
Organism
Homo sapiens
Gene name
ICOS
Gene synonyms
AILIM
NCBI Gene ID
Protein name
inducible T-cell costimulator
Protein synonyms
Activation-inducible lymphocyte immunomediatory molecule, CD278, inducible costimulator, inducible T-cell co-stimulator
Uniprot ID
Mouse ortholog
Icos (54167)
inducible T-cell costimulator (Q9WVS0)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 28 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more